Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness-Reference-Cited by-同舟云学术

Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness

Published:1995-10 Issue:10 Volume:26 Page:1133-1138
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Buø Laila,Meling Gunn Iren,Karlsrud Tove S,Johansen Harald T,Aasen Ansgar O

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference43 articles.

1. Vævsdestruksjon og cancer;Skriver;Nord Med,1983

2. Plasminogen activators, tissue degradation, and cancer;Danø;Adv Cancer Res,1985

3. Proteolytic enzymes in cancer invasion and metastasis;Goldfarb;Semin Thromb Hemost,1986

4. Do proteases play a role in cancer invasion and metastasis?;Duffy;Eur J Cancer Clin Oncol,1987

5. The role of proteolytic enzymes in cancer invasion and metastasis;Duffy;Clin Exp Metastasis,1992

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Targeting the Urokinase Plasminogen Activator with Nanotherapeutics;Molecular Pharmaceutics;2023-04-29

2. Less aggressive treatment for less aggressive disease? A retrospective single‐center study of pulmonary‐limited metastases associated with colorectal cancer;Asia-Pacific Journal of Clinical Oncology;2023-01-24

3. The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets;Biomolecules;2022-01-18

4. The Soluble Urokinase-Type Plasminogen Activator Receptor as a Biomarker for Survival and Early Treatment Effect in Metastatic Colorectal Cancer;Cancers;2021-10-12

5. The current understanding on the impact of KRAS on colorectal cancer;Biomedicine & Pharmacotherapy;2021-08